TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the recommended dose of the sustained-release form
of BPS (TRK-100STP low dose or high dose) in Japanese patients with CRF (Primary glomerular
disease/nephrosclerosis).